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Introduction: Abdominal aortic aneurysm (AAA) is the most
common form of aortic aneurysm and is deﬁned as a dila-
tion of the diameter of the aorta by at least 50%. It is a
major and rising cause of mortality in the Western world in
elderly people. The immune system has been implicated, in
part, in the pathogenesis of this condition and we therefore
aimed to investigate whether individuals with immune-
mediated diseases have an increased risk of subsequent
AAA.
Methods: We carried out a record-linkage study analysing
datasets of linked hospital admissions and death registra-
tions for the whole of England from January 1999 to
December 2011. Rate ratios for AAA were calculated by
comparing the occurrence of AAA in people with and
without immune-mediated diseases.
Results: We found a signiﬁcantly increased risk of AAA
following hospital admission or day case care for the
following immune-mediated diseases: asthma, autoim-
mune haemolytic anaemia, chronic active hepatitis,
Crohn’s disease, dermatomyositis, idiopathic thrombocy-
topenic purpura, multiple sclerosis, myxoedema, perni-
cious anaemia, primary biliary cirrhosis, psoriasis,
rheumatoidarthritis, scleroderma, Sjogren’s syndrome,
systemic lupus erythematosus (SLE), thyrotoxicosis and
ulcerative colitis. Rate ratios of two or greater were found
for SLE (rate ratio (RR) ¼ 2.84, 95% conﬁdence interval
(95%CI) 2.36e3.39, p < 0.001), chronic active hepatitis
(RR ¼ 2.48, 1.75e3.42, p < 0.001), dermatomyositis (RR
¼ 2.20, 1.24e3.65, p ¼ 0.003), asthma (RR ¼ 2.05, 1.79e
2.35, p < 0.001) and primary biliary cirrhosis (RR ¼ 2.28,
1.80e2.85, p < 0.001). When we split the outcomes into
AAA with and without mention of rupture, there were no
signiﬁcant differences in the RR for 26 of the 27 immune-
mediated diseases studied. There was nonetheless an
overall trend of higher RRs for unruptured than ruptured
AAA, suggesting that ruptured AAA may be an underesti-
mate of AAA in these cohorts due to some surveillance
bias and subsequent increased detection (and treatment)
of AAA prior to rupture.
Conclusion: Our study suggests an increased risk of subse-
quent AAA in individuals admitted to hospital with some
immune-mediated diseases.
Further work is needed to conﬁrm or refute our ﬁnd-
ings, but, if conﬁrmed, where the risk is particularly
elevated physicians should be mindful of this and of thepossible merits of offering screening for AAA to such
people.
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Introduction: Abdominal aortic aneurysm (AAA) is an aortic
dilatative affection, with high mortality risk associated with
wall rupture. Inﬂammatory process and extracellular matrix
degradation by metalloproteinases (MMPs) are involved in
AAA pathogenesis. Recently, a niche of mesenchymal stro-
mal cells (MSCs) with stemness properties and immuno-
modulatory ability has been discovered in different vascular
segments of healthy donors. The aim of the present study
was to verify the presence of mesenchymal progenitors also
in the aneurysmal tissue and investigate their role in AAA
pathogenesis.
Methods: Vascular tissues from AAA patients (n ¼ 15
males, mean age ¼ 66,1 years) were digested in an enzy-
matic solution. The cell population obtained was expanded
in vitro and analyzed for stemness markers (Nanog, Oct-4,
Sox-2) by RT-PCR. mRNA levels of AAA mediators (MMP2,
MMP9) were quantiﬁed using Real Time PCR in MSCs iso-
lated from aneurysm (AAA MSCs). MSCs derived from
thoracic aorta of healthy donors (hMSCs) were used as
controls. mRNA levels of anti-inﬂammatory cytokines IL-10
and HLA-G were detected in AAA and healthy MSCs to
investigate their immunomodulatory ability; co-culture of
activated peripheral blood mononuclear cells (MNCs) and
MSCs from aneurysm and healthy tissues was assessed to
verify MSCs inhibitory action on MNCs proliferation by
BromoDeoxyUridine incorporation assay. We tested the in
vitro effect of soluble IL-10 added to AAA MSCs to explore a
potential strategy of MMP9 modulation.
Results: MSCs successfully isolated from the aneurysmal
tissues expressed the stemness markers, as demonstrated
by RT-PCR. AAA MSCs showed MMP2 mRNA levels similar
to the control group, while MMP9 mRNA levels resulted
400-fold higher than controls. Immunoblotting conﬁrmed
MMP-9 increase in AAA patients. Compared to hMSCs,
AAA MSCs did not express HLA-G and exerted a less
immunosuppressive effect on MNCs proliferation (mean
BrdU incorporation 1.74  0.09 vs 2.41  0.19; p value
¼ 0.03, t test). IL-10 transcriptional levels were lower in
